SCHEMBL23913406

SCHEMBL23913406

c1ccc(-c2cccc3c2oc2cc(-c4nc(-c5cccc(-c6cccc7sc8ccccc8c67)c5)nc(-c5ccc6c(c5)oc5ccccc56)n4)ccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.45
PRKDC P78527 4/20 0.41
GGPS1 O95749 1/20 0.37
BRDT Q58F21 1/20 0.36
PTGES2 Q9H7Z7 1/20 0.35
LIMK1 P53667 1/20 0.33
MAPT P10636 2/20 0.33
F9 P00740 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
HCRTR1 O43613 1/20 0.32
MMP12 P39900 1/20 0.32
MMP13 P45452 1/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CB P42338 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CDC14B O60729 1/20 0.32
CDC14A Q9UNH5 1/20 0.32
PRMT5 O14744 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23913837 0.97 ALOX5 (0.43) ALOX5PRKDCGGPS1BRDTPTGES2
SCHEMBL23349761 0.94 ALOX5 (0.45) ALOX5PRKDCGGPS1BRDTPTGES2
SCHEMBL23349606 0.94 ALOX5 (0.45) ALOX5PRKDCGGPS1BRDTPTGES2
SCHEMBL23349590 0.93 ALOX5 (0.40) ALOX5PRKDCGGPS1BRDTPTGES2
SCHEMBL24264151 0.93 ALOX5 (0.40) ALOX5PRKDCGGPS1BRDTPTGES2
SCHEMBL23349433 0.93 ALOX5 (0.41) ALOX5PRKDCGGPS1BRDTPTGES2
SCHEMBL25645972 0.93 ALOX5 (0.43) ALOX5PRKDCGGPS1BRDTPTGES2
SCHEMBL24216749 0.93 ALOX5 (0.39) ALOX5PRKDCGGPS1BRDTPTGES2
SCHEMBL23913828 0.93 PRKDC (0.35) ALOX5PRKDCBRDTLIMK1MAPT
SCHEMBL23349876 0.92 ALOX5 (0.40) ALOX5PRKDCGGPS1BRDTPTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, TRPC1 ALOX5 1095/4885PRKDC 4327/4885GGPS1 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.